You are here
FDA cracks down on Juul and e-cigarette retailers
[WASHINGTON] The Food and Drug Administration (FDA) on Wednesday declared that teenage use of electronic cigarettes has reached "an epidemic proportion", and it put makers of the most popular devices on notice that they have just 60 days to prove they can keep their devices away from minors.
The order was part of a sweeping government action that targeted both makers and sellers of e-cigarettes. If Juul Labs and four other major manufacturers fail to halt sales to minors, the agency said, it could remove their flavoured products from the market. It also raised the possibility of civil or criminal charges if companies are allowing bulk sales through their websites.
The agency said it was sending warning letters to 1,100 retailers — including 7-Eleven stores, Walgreens, Circle K convenience shops and Shell gas stations — and issued another 131 fines, ranging from US$279 to US$11,182, for selling e-cigarettes to minors.
Federal law prohibits selling e-cigarettes to anyone under 18. In a briefing with reporters, the FDA commissioner, Scott Gottlieb, said that more than 2 million middle and high school students were regular users of e-cigarettes last year.
The government's tactics underscore a dilemma in the public health community: In addressing one public health problem — cigarette smoking, which kills 480,000 people in the United States each year — e-cigarettes are creating another — hooking teenagers who have never smoked on nicotine.
E-cigarette users inhale far fewer toxic chemicals than do smokers of traditional cigarettes. But they can take in higher levels of nicotine, which is addictive.
"The developing adolescent brain is particularly vulnerable to addiction," the FDA said in its statement announcing the actions.
In particular, the agency has been watching the wildly popular Juul, which offers especially potent nicotine hits. Juul Labs launched the sleek device, which looks like a flash drive, in 2015. It comes with "pods" in eight flavours, among them mango, menthol and creme. In a short time, Juul has become the dominant seller of e-cigarettes and a fad among students. According to Nielsen data, Juul controls 72 per cent of the market, and is valued by investors at US$16 billion.
In a statement, a Juul spokesman said: "Juul Labs will work proactively with FDA in response to its request. We are committed to preventing underage use of our product, and we want to be part of the solution in keeping e-cigarettes out of the hands of young people."
Dr Gottlieb said the FDA would look closely at whether Juul and other manufacturers were allowing bulk purchases of products through their own websites — a practice where the buyer could then sell to minors.
If such "straw sales" are happening, it should be readily apparent to the manufacturers, he said. "If the companies don't know, or if they don't want to know, we'll now be helping to identify it for them."
The other four products facing the 60-day deadline are RJR Vapor Co's Vuse, Imperial Grand's blu and devices made by Logic. They said they were working with the FDA as well.
RJR, Imperial and Altria are all major tobacco companies. As smoking rates have declined, the industry sees e-cigarettes as an important piece of its survival, a fact that makes some in public health mistrustful.
"They say they've changed from the days of Joe Camel," Dr Gottlieb said. "But look at what's happening right now, on our watch and on their watch. They must demonstrate that they're truly committed to keeping these new products out of the hands of kids."
Dr Gottlieb has said many times he believes that e-cigarettes and similar products known as electronic nicotine delivery systems may be effective options for adults who want to stop smoking but still crave nicotine. But he said teenage vaping has become so concerning that regulators may have to curb the availability of the devices to keep them out of the hands of youths.
"Inevitably what we are going to have to contemplate are actions that may narrow the off-ramp for adults who see e-cigarettes as a viable alternative to combustible tobacco in order to close the on ramp for kids," Dr Gottlieb said. "It's an unfortunate trade-off."
Dr Gottlieb's aggressive approach against private industry is unusual for an official in the business-friendly Trump administration which has sought to roll back numerous environmental and health regulations. But critics said that his decision last summer to extend a deadline for e-cigarette manufacturers to demonstrate that their products comply with public health concerns helped perpetuate the current problem.
"It's nice they want to do something but realistically, what are they going to accomplish this way when they could be so much more effective by following the regulatory plan that had been ready to put into place and that the commissioner postponed?" said Diana Zuckerman, president of the National Center for Health Research, a non-profit health policy group.
She also pointed to the popularity of vaping among young adults. Researchers generally believe that the adolescent brain continues to develop through age 26. "It's a big epidemic among people ages 18 to 30, too, " she said.
And while the FDA's announcement struck many as tough, legal experts said the agency could face a protracted legal fight if it follows through on its threats to ban flavours bans and curtail marketing.
Marc Scheineson, a healthcare lawyer and a former associate FDA commissioner, said that the agency was relying on public opinion and its own bully pulpit to push the targeted manufacturers into "voluntary compliance".
Some anti-smoking groups, while encouraged by the FDA's actions, expressed caution: "Asking the tobacco industry to come up with solutions is the proverbial case of asking the fox to guard the hen house," said Robin Koval, the president and chief executive of Truth Initiative. "After decades, there is no evidence that the tobacco industry is able to regulate itself."
In April, the FDA announced it was investigating Juul's marketing practices to determine if the company deliberately targeted youths. The agency requested reams of documents from the company, including focus group reports and toxicology studies. Juul has submitted thousands of pages of records to the agency, but neither the FDA nor Juul have made them public. Gottlieb said the agency's tobacco division is still poring through them.
Risa Robinson, a professor of mechanical engineering at Rochester Institute of Technology, began studying e-cigarettes six years ago for the FDA. The early products did not have enough nicotine to cause concern, she said. But later products, like Juul, had more nicotine and, she said, can become even stronger depending on how deeply a user puffs.
"I'm highly concerned now," Prof Robinson said. Beyond nicotine, the addition of heat to the e-liquid flavours generates chemicals that have not yet been studied in depth, she added.
The attorney general of Massachusetts, Maura Healey, who recently began an investigation into the marketing and sale of e-cigarettes to minors, praised the FDA's action.
"We've worked too hard over the past 50 years to reduce smoking rates among young people to let these companies profit off of getting them hooked on nicotine," Healey said. "This move by the FDA is a good first step to shut down companies targeting minors."